Thanks for the reply twigman. I thought that there may have been some investors who were personally affected by the autoimmune processes.
I like you am personally invested and have been since the early CBio days. I work in the medical industry and see the effects of autoimmune disease on patient, so I invested in the science.
On a side not it is good to see that we have passed March 25th (the acceptance date for new shares) and the price didn't drop below the .075 mark. I am taking this as good news as would mean that one would think that most holders would take up their full allotment.
Does everyone else think that this should push the SP up, or will it drop again after these "new shares" are issued out and can be released onto market?
IVX Price at posting:
7.7¢ Sentiment: LT Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)